Back to search
FDAFDA · Food and drugs·Recall number D-0065-2019

dr. brandt, BB cream with signature FLEXITONE, SPF 30, 1 oz./30 g tube, Distributed by: Cosmetic Dermatology, Inc., Miami, FL 33172, UPC 6 63963 00828 7.

Published October 24, 2018 · Recall initiated: August 3, 2018

Summary

FDA records drug Class II recall D-0065-2019, published October 24, 2018 and initiated August 3, 2018. Recalling firm: Product Quest Manufacturing LLC; Status: Terminated; Reported quantity: 9,480 tubes; Lot: Lot: 161223D, Exp. 4/16/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: separation of product and failure for actives.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Product Quest Manufacturing LLC
Distributor
Nationwide in the USA
Lot
Lot: 161223D, Exp. 4/16/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was dr. brandt, BB cream with signature FLEXITONE, SPF 30, 1 oz./30 g tube, Distributed by: Cosmetic Dermatology, Inc., Miami, FL 33172, UPC 6 63963 00828 7. recalled?

Yes. FDA published recall D-0065-2019 on October 24, 2018. Reported hazard: Failed Stability Specifications: separation of product and failure for actives.

What should I do if I have this product?

Voluntary: Firm initiated · Letter